BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 2446113)

  • 1. Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors.
    Weiland GA; Durkin JA; Henley JM; Simasko SM
    Mol Pharmacol; 1987 Nov; 32(5):625-32. PubMed ID: 2446113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the binding of [3H]substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque.
    Min CK; Owens J; Weiland GA
    Mol Pharmacol; 1994 Feb; 45(2):221-7. PubMed ID: 7509439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The muscarinic antagonists aprophen and benactyzine are noncompetitive inhibitors of the nicotinic acetylcholine receptor.
    Amitai G; Herz JM; Bruckstein R; Luz-Chapman S
    Mol Pharmacol; 1987 Nov; 32(5):678-85. PubMed ID: 3683366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of substance P on the binding of agonists to the nicotinic acetylcholine receptor of Torpedo electroplaque.
    Min CK; Weiland GA
    J Neurochem; 1993 Jun; 60(6):2238-46. PubMed ID: 7684070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes.
    Dodson BA; Braswell LM; Miller KW
    Mol Pharmacol; 1987 Jul; 32(1):119-26. PubMed ID: 3600612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: relevance to their toxicities.
    Katz EJ; Cortes VI; Eldefrawi ME; Eldefrawi AT
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):227-36. PubMed ID: 9344890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants involved in the affinity of alpha-conotoxins GI and SI for the muscle subtype of nicotinic acetylcholine receptors.
    Groebe DR; Gray WR; Abramson SN
    Biochemistry; 1997 May; 36(21):6469-74. PubMed ID: 9174364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1996 Sep; 333(1):1-11. PubMed ID: 8806747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cembranoid interaction with the nicotinic acetylcholine receptor.
    Hann RM; Pagán OR; Gregory L; Jácome T; Rodríguez AD; Ferchmin PA; Lu R; Eterović VA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):253-60. PubMed ID: 9765345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of phencyclidine binding to the acetylcholine receptor from Torpedo electroplaque.
    Oswald RE; Bamberger MJ; McLaughlin JT
    Mol Pharmacol; 1984 May; 25(3):360-8. PubMed ID: 6727862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P inhibits carbamylcholine-stimulated 22Na+ efflux from acetylcholine receptor-enriched Torpedo electroplaque membrane vesicles.
    Min CK; Weiland GA
    Brain Res; 1992 Jul; 586(2):348-51. PubMed ID: 1381656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of binding of a benzomorphan opiate to the acetylcholine receptor from Torpedo electroplaque.
    Oswald RE; Michel L; Bigelow J
    Mol Pharmacol; 1986 Feb; 29(2):179-87. PubMed ID: 3951431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of high-affinity nicotinic [3H]acetylcholine binding sites.
    Lukas RJ
    J Pharmacol Exp Ther; 1990 Apr; 253(1):51-7. PubMed ID: 2329523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of 3H-nicotine, 125I-kappa-bungarotoxin, and 125I-alpha-bungarotoxin binding to nicotinic sites in the chicken forebrain and midbrain.
    Sorenson EM; Chiappinelli VA
    J Comp Neurol; 1992 Sep; 323(1):1-12. PubMed ID: 1430311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of the thymic polypeptide hormone thymopoietin with neuronal nicotinic alpha-bungarotoxin binding sites and with muscle-type, but not ganglia-type, nicotinic acetylcholine receptor ligand-gated ion channels.
    Lukas RJ; Audhya T; Goldstein G; Lucero L
    Mol Pharmacol; 1990 Dec; 38(6):887-94. PubMed ID: 1701215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist binding to the Torpedo acetylcholine receptor. 1. Complexities revealed by dissociation kinetics.
    Dunn SM; Raftery MA
    Biochemistry; 1997 Apr; 36(13):3846-53. PubMed ID: 9092814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple binding sites for phencyclidine on the nicotinic acetylcholine receptor from Torpedo ocellata electric organ.
    Haring R; Kloog Y
    Life Sci; 1984 Mar; 34(11):1047-55. PubMed ID: 6700368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization of the nicotinic acetylcholine receptor by diisopropylfluorophosphate.
    Eldefrawi ME; Schweizer G; Bakry NM; Valdes JJ
    J Biochem Toxicol; 1988; 3():21-32. PubMed ID: 3236333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM; Yaksh TL; Taylor P
    J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.